Last reviewed · How we verify

NCT04729842

Comparison Between Bupivacaine and Ropivacaine in Patients Undergoing Forearm Surgeries Under Brachial Plexus Block

Completed NA Last updated 10 February 2021
What this trial tests

NA trial testing Axillary Brachial plexus block in Effect of Drug in 100 participants. Completed in 1 June 2017.

Timeline
1 July 2016
Primary endpoint
1 June 2017
1 June 2017

Quick facts

Lead sponsorAssam Medical College
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date1 July 2016
Primary completion1 June 2017
Estimated completion1 June 2017

Drugs / interventions tested

Conditions studied

Sponsor

Assam Medical College

Who can join

Adults 18 to 60, any sex, with Effect of Drug. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This prospective comparative randomized study was done to compare Bupivacaine and Ropivacaine in patients undergoing forearm surgeries under axillary brachial plexus block. The study compares the onset and duration of sensory block, onset and duration of motor block and duration of analgesia between these two drugs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Effect of Drug

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04729842.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing